E I du Pont de Nemours and Co (DD)

DD on New York Consolidated

59.08USD
9 Feb 2016
Change (% chg)

-- (--)
Prev Close
$59.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,557,732
52-wk High
$76.61
52-wk Low
$47.11

DD

Chart for DD

About

E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company's subsidiaries and affiliates conduct manufacturing, seed production or selling activities and distribute products manufactured by the Company. The Company's segments include Agriculture, Electronics & Communications, Industrial... (more)

Overall

Beta: 1.70
Market Cap(Mil.): $51,498.91
Shares Outstanding(Mil.): 871.68
Dividend: 0.38
Yield (%): 2.57

Financials

  DD Industry Sector
P/E (TTM): 28.32 17.54 23.03
EPS (TTM): 2.09 -- --
ROI: 5.64 4.72 6.00
ROE: 16.45 5.41 9.26
Search Stocks

DuPont faces 40 trials a year over cancer tied to Teflon chemical

NEW YORK Chemical maker DuPont will face 40 trials a year starting April 2017 involving plaintiffs who say they developed cancer from a toxic chemical used to make Teflon that leaked from one of the company’s plants in West Virginia.

28 Jan 2016

DuPont faces 40 trials a year over cancer tied to Teflon chemical

NEW YORK Chemical maker DuPont will face 40 trials a year starting April 2017 involving plaintiffs who say they developed cancer from a toxic chemical used to make Teflon that leaked from one of the company's plants in West Virginia.

28 Jan 2016

DuPont faces 40 trials a year over cancer tied to Teflon chemical

NEW YORK, Jan 28 Chemical maker DuPont will face 40 trials a year starting April 2017 involving plaintiffs who say they developed cancer from a toxic chemical used to make Teflon that leaked from one of the company's plants in West Virginia.

28 Jan 2016

DuPont doubles down on cost cuts ahead of Dow Chemical merger

Chemicals and seed producer DuPont's quarterly profit topped analysts' estimates as the company intensifies its cost-cutting efforts ahead of its merger with Dow Chemical Co .

26 Jan 2016

DuPont CEO sees 'very little' to concern regulators in Dow merger

DuPont Chief Executive Edward Breen said on Tuesday that there was "very little" to concern regulators about the company's pending merger with Dow Chemical Co and that it was unlikely to have to make significant asset sales.

26 Jan 2016

UPDATE 2-DuPont CEO sees "very little" to concern regulators in Dow merger

Jan 26 DuPont Chief Executive Edward Breen said on Tuesday that there was "very little" to concern regulators about the company's pending merger with Dow Chemical Co and that it was unlikely to have to make significant asset sales.

26 Jan 2016

DuPont sees no significant asset sales ahead of Dow merger-CEO

Jan 26 Chemicals and seed producer DuPont is unlikely to have to make significant asset sales to get regulatory clearance for its merger with Dow Chemical Co , DuPont CEO Edward Breen told Reuters.

26 Jan 2016

CORRECTED-UPDATE 2-DuPont doubles down on cost cuts ahead of Dow Chemical merger

* Sees 2016 operating profit of $2.95-$3.10/shr vs est. $3.10

26 Jan 2016

UPDATE 3-DuPont doubles down on cost cuts ahead of Dow Chemical merger

* Sees 2016 operating profit of $2.95-$3.10/shr vs est. $3.10

26 Jan 2016

DuPont sales drop on strong dollar

Jan 26 Chemicals and seed producer DuPont reported lower quarterly sales largely due to a strong dollar.

26 Jan 2016

Earnings vs. Estimates

Search Stocks